Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1313579
[patent_doc_number] => 06610732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Anti-constipation composition'
[patent_app_type] => B2
[patent_app_number] => 10/138650
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6071
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138650 | Anti-constipation composition | May 5, 2002 | Issued |
Array
(
[id] => 6725619
[patent_doc_number] => 20030207931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'USE OF 3-(2-ETHYLPHENYL)-5-(3-METHOXYPHENYL)-1H-1,2,4-TRIAZOLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES'
[patent_app_type] => new
[patent_app_number] => 10/137699
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4125
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10137699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/137699 | Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases | May 2, 2002 | Issued |
Array
(
[id] => 1202900
[patent_doc_number] => 06720345
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-13
[patent_title] => 'Semicarbazone derivatives and their use as thrombopoietin mimetics'
[patent_app_type] => B1
[patent_app_number] => 10/129211
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5324
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/720/06720345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129211 | Semicarbazone derivatives and their use as thrombopoietin mimetics | May 2, 2002 | Issued |
Array
(
[id] => 7622232
[patent_doc_number] => 06977269
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-20
[patent_title] => 'Method of improving animal tissue quality'
[patent_app_type] => utility
[patent_app_number] => 10/136472
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7277
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136472 | Method of improving animal tissue quality | Apr 30, 2002 | Issued |
10/129235 | Pharmaceutical compositions | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6329402
[patent_doc_number] => 20020198182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Malignant tumor metastasis inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/135846
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2995
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135846
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135846 | Malignant tumor metastasis inhibitors | Apr 30, 2002 | Issued |
Array
(
[id] => 6736104
[patent_doc_number] => 20030013739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia'
[patent_app_type] => new
[patent_app_number] => 10/135793
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17570
[patent_no_of_claims] => 309
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135793 | Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia | Apr 29, 2002 | Abandoned |
10/111957 | Method for administering a phosphodiesterase 4 inhibitor | Apr 28, 2002 | Abandoned |
Array
(
[id] => 5788444
[patent_doc_number] => 20020160965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Cosmetic and dermatological formulations comprising flavonoids'
[patent_app_type] => new
[patent_app_number] => 10/128766
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8775
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128766 | Cosmetic and dermatological preparation with flavonoids | Apr 22, 2002 | Issued |
Array
(
[id] => 1342626
[patent_doc_number] => 06586417
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans'
[patent_app_type] => B1
[patent_app_number] => 10/063415
[patent_app_country] => US
[patent_app_date] => 2002-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2594
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586417.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063415
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063415 | Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans | Apr 21, 2002 | Issued |
Array
(
[id] => 5788837
[patent_doc_number] => 20020161038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Prodrugs of carbamate inhibitors of IMPDH'
[patent_app_type] => new
[patent_app_number] => 10/125617
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13092
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125617 | Prodrugs of carbamate inhibitors of IMPDH | Apr 16, 2002 | Issued |
Array
(
[id] => 6756422
[patent_doc_number] => 20030004199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Method for preventing or treating pulmonary inflammation by administering an endothelin antagonist'
[patent_app_type] => new
[patent_app_number] => 10/121039
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2308
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121039 | Method for preventing or treating pulmonary inflammation by administering an endothelin antagonist | Apr 10, 2002 | Abandoned |
09/936128 | Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv | Apr 8, 2002 | Abandoned |
Array
(
[id] => 6412774
[patent_doc_number] => 20020183240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Antineoplastic combinations'
[patent_app_type] => new
[patent_app_number] => 10/117161
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4711
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117161 | Antineoplastic combinations | Apr 4, 2002 | Abandoned |
Array
(
[id] => 1337650
[patent_doc_number] => 06593331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-15
[patent_title] => 'Method for treatment of pain'
[patent_app_type] => B2
[patent_app_number] => 10/115785
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6477
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115785 | Method for treatment of pain | Apr 3, 2002 | Issued |
Array
(
[id] => 1202880
[patent_doc_number] => 06720337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-13
[patent_title] => 'Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative'
[patent_app_type] => B2
[patent_app_number] => 10/106227
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5870
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 465
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/720/06720337.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106227
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106227 | Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative | Mar 26, 2002 | Issued |
Array
(
[id] => 1282039
[patent_doc_number] => 06642258
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Use of central cannabinoid receptor antagonist for preparing medicines'
[patent_app_type] => B1
[patent_app_number] => 10/088704
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1300
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642258.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088704 | Use of central cannabinoid receptor antagonist for preparing medicines | Mar 20, 2002 | Issued |
Array
(
[id] => 5845424
[patent_doc_number] => 20020132830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Use of beta 2 bronchodilator drugs'
[patent_app_type] => new
[patent_app_number] => 10/095846
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6801
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095846
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095846 | Use of beta 2 bronchodilator drugs | Mar 11, 2002 | Abandoned |
Array
(
[id] => 6756364
[patent_doc_number] => 20030004141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Medical devices, compositions and methods for treating vulnerable plaque'
[patent_app_type] => new
[patent_app_number] => 10/096131
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8101
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004141.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096131 | Medical devices, compositions and methods for treating vulnerable plaque | Mar 7, 2002 | Abandoned |
Array
(
[id] => 5845316
[patent_doc_number] => 20020132793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Use of methylphenidate compounds to enhance memory'
[patent_app_type] => new
[patent_app_number] => 10/087232
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24644
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087232 | Use of methylphenidate compounds to enhance memory | Feb 27, 2002 | Abandoned |